{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:16:40Z","timestamp":1790774200072,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Health and Medical Research Council","award":["1080206"],"award-info":[{"award-number":["1080206"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1149987"],"award-info":[{"award-number":["1149987"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Individuals with diabetes and lower-limb complications are at high risk for cardiovascular and all-cause mortality, but uncertainties remain in terms of cancer-related death in this population. We investigated this relationship in a large cohort of people with type 2 diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used data from the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study. The primary outcome was adjudicated cancer death; secondary outcomes were overall and site-specific incident cancers, determined according to the International Classification of Diseases Code (ICD-10). We compared outcomes in individuals with (<jats:italic>versus<\/jats:italic> without) a baseline history of lower-limb complications (peripheral artery disease (PAD) or sensory peripheral neuropathy) using Cox regression models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 11,140 participants (women 42%, mean age 66\u00a0years), lower-limb complications were reported at baseline in 4293 (38%) individuals: 2439 (22%) with PAD and 2973 (27%) with peripheral neuropathy. Cancer death occurred in 316 (2.8%) participants during a median of 5.0 (25th\u201375th percentile, 4.7\u20135.1) years of follow-up corresponding to 53,550 person-years and an incidence rate of 5.9 (95% CI 5.3\u20136.6) per 1000 person-years. The risk of cancer death was higher in individuals with (<jats:italic>versus<\/jats:italic> without) lower-limb complication [hazard ratio 1.53 (95% CI, 1.21\u20131.94), <jats:italic>p<\/jats:italic>\u2009=\u20090.0004], PAD [1.32 (1.02\u20131.70), <jats:italic>p<\/jats:italic>\u2009=\u20090.03] or neuropathy (1.41 (1.11\u20131.79), <jats:italic>p<\/jats:italic>\u2009=\u20090.004], adjusting for potential confounders and study allocations. PAD, but not neuropathy, was associated with excess risk of incident cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PAD and peripheral neuropathy were independently associated with increased 5-year risk of cancer death in individuals with type 2 diabetes. PAD was also associated with increased risk of incident cancers. Our findings provide new evidence on the non-cardiovascular prognostic burden of lower-limb complications in people with type 2 diabetes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-020-01198-y","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T21:03:44Z","timestamp":1609794224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["History of lower-limb complications and risk of cancer death in people with type 2 diabetes"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-1197","authenticated-orcid":false,"given":"Kamel","family":"Mohammedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"9498","key":"1198_CR1","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","volume":"366","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719\u201324.","journal-title":"Lancet"},{"issue":"24","key":"1198_CR2","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367\u201375.","journal-title":"N Engl J Med"},{"issue":"1","key":"1198_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-018-0781-1","volume":"17","author":"M Nativel","year":"2018","unstructured":"Nativel M, Potier L, Alexandre L, Baillet-Blanco L, Ducasse E, Velho G, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018;17(1):138.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1198_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1198_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2337\/dc18-1380","volume":"42","author":"LS Geiss","year":"2019","unstructured":"Geiss LS, Li Y, Hora I, Albright A, Rolka D, Gregg EW. Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population. Diabetes Care. 2019;42(1):50\u20134.","journal-title":"Diabetes Care"},{"issue":"2","key":"1198_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2337\/dc08-1639","volume":"32","author":"A Johannesson","year":"2009","unstructured":"Johannesson A, Larsson GU, Ramstrand N, Turkiewicz A, Wirehn AB, Atroshi I. Incidence of lower-limb amputation in the diabetic and nondiabetic general population: a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care. 2009;32(2):275\u201380.","journal-title":"Diabetes Care"},{"issue":"7","key":"1198_CR7","doi-asserted-by":"publisher","first-page":"e41492","DOI":"10.1371\/journal.pone.0041492","volume":"7","author":"CM Buckley","year":"2012","unstructured":"Buckley CM, O\u2019Farrell A, Canavan RJ, Lynch AD, De La Harpe DV, Bradley CP, et al. Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland. PLoS ONE. 2012;7(7):e41492.","journal-title":"PLoS ONE"},{"issue":"8","key":"1198_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/dme.13973","volume":"36","author":"M Kerr","year":"2019","unstructured":"Kerr M, Barron E, Chadwick P, Evans T, Kong WM, Rayman G, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995\u20131002.","journal-title":"Diabet Med"},{"issue":"5","key":"1198_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc19-1614","volume":"43","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020;43(5):964\u201374.","journal-title":"Diabetes Care"},{"issue":"11","key":"1198_CR10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/dme.13054","volume":"33","author":"JW Walsh","year":"2016","unstructured":"Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493\u20138.","journal-title":"Diabet Med"},{"issue":"1","key":"1198_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","volume":"15","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P, et al. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol. 2016;15(1):129.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"1198_CR12","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.2337\/dc16-1594","volume":"39","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Zoungas S, Li Q, Harrap S, Patel A, et al. Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes. Diabetes Care. 2016;39(12):2270\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"1198_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00125-019-4812-6","volume":"62","author":"L Bjerg","year":"2019","unstructured":"Bjerg L, Hulman A, Carstensen B, Charles M, Witte DR, Jorgensen ME. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study. Diabetologia. 2019;62(4):633\u201343.","journal-title":"Diabetologia"},{"issue":"4","key":"1198_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jvs.2014.04.052","volume":"60","author":"JR Brownrigg","year":"2014","unstructured":"Brownrigg JR, Griffin M, Hughes CO, Jones KG, Patel N, Thompson MM, et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J Vasc Surg. 2014;60(4):982-6.e3.","journal-title":"J Vasc Surg"},{"issue":"9859","key":"1198_CR15","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"issue":"9","key":"1198_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829\u201341.","journal-title":"N Engl J Med"},{"issue":"9","key":"1198_CR17","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.2337\/dc12-0002","volume":"35","author":"PT Campbell","year":"2012","unstructured":"Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care. 2012;35(9):1835\u201344.","journal-title":"Diabetes Care"},{"issue":"1","key":"1198_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00125-019-04991-x","volume":"63","author":"JL Harding","year":"2020","unstructured":"Harding JL, Andes LJ, Gregg EW, Cheng YJ, Weir HK, Bullard KM, et al. Trends in cancer mortality among people with vs without diabetes in the USA, 1988\u20132015. Diabetologia. 2020;63(1):75\u201384.","journal-title":"Diabetologia"},{"key":"1198_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.09.023","author":"S Ling","year":"2020","unstructured":"Ling S, Brown K, Miksza JK, Howells LM, Morrison A, Issa E, et al. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts. Nutr Metab Cardiovasc Dis. 2020. https:\/\/doi.org\/10.1016\/j.numecd.2020.09.023.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1198_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijcard.2020.04.080","volume":"317","author":"JC Youn","year":"2020","unstructured":"Youn JC, Chung WB, Ezekowitz JA, Hong JH, Nam H, Kyoung DS, et al. Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort study. Int J Cardiol. 2020;317:167\u201373.","journal-title":"Int J Cardiol"},{"issue":"8","key":"1198_CR21","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/ndt\/gfs022","volume":"27","author":"G Wong","year":"2012","unstructured":"Wong G, Zoungas S, Lo S, Chalmers J, Cass A, Neal B, et al. The risk of cancer in people with diabetes and chronic kidney disease. Nephrol Dial Transplant. 2012;27(8):3337\u201344.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1198_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jdiacomp.2012.11.007","volume":"27","author":"TY Yu","year":"2013","unstructured":"Yu TY, Li HY, Jiang YD, Chang TJ, Wei JN, Chuang LM. Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes. J Diabetes Complications. 2013;27(3):201\u20137.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"1198_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12933-020-01052-1","volume":"19","author":"CD Bendor","year":"2020","unstructured":"Bendor CD, Bardugo A, Pinhas-Hamiel O, Afek A, Twig G. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. Cardiovasc Diabetol. 2020;19(1):79.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1198_CR24","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s001250100612","volume":"44","author":"ADVANCE Management Committee","year":"2001","unstructured":"ADVANCE Management Committee. Study rationale and design of ADVANCE: action in diabetes and vascular disease\u2013preterax and diamicron MR controlled evaluation. Diabetologia. 2001;44(9):1118\u201320.","journal-title":"Diabetologia"},{"issue":"9590","key":"1198_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","volume":"370","author":"A Patel","year":"2007","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829\u201340.","journal-title":"Lancet"},{"issue":"24","key":"1198_CR26","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"10","key":"1198_CR27","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285\u201393.","journal-title":"Diabetes Care"},{"issue":"7","key":"1198_CR28","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00125-011-2104-x","volume":"54","author":"G Stefansdottir","year":"2011","unstructured":"Stefansdottir G, Zoungas S, Chalmers J, Kengne AP, Knol MJ, Leufkens HG, et al. Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia. 2011;54(7):1608\u201314.","journal-title":"Diabetologia"},{"key":"1198_CR29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"1198_CR30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1158\/1055-9965.EPI-14-1255","volume":"24","author":"T Onega","year":"2015","unstructured":"Onega T, Baron JA, Johnsen SP, Pedersen L, Farkas DK, Sorensen HT. Cancer risk and subsequent survival after hospitalization for intermittent claudication. Cancer Epidemiol Biomarkers Prev. 2015;24(4):744\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1198_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3400\/avd.oa.18-00155","volume":"12","author":"A Akai","year":"2019","unstructured":"Akai A, Shigematsu H, Miyata T, Maeda H, Onohara T, Sato O, et al. Increased incidence of cancer in japanese patients with critical limb ischemia. Ann Vasc Dis. 2019;12(2):182\u20136.","journal-title":"Ann Vasc Dis"},{"issue":"7","key":"1198_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.117.032617","volume":"138","author":"J Sundboll","year":"2018","unstructured":"Sundboll J, Veres K, Horvath-Puho E, Adelborg K, Sorensen HT. Risk and Prognosis of Cancer After Lower Limb Arterial Thrombosis. Circulation. 2018;138(7):669\u201377.","journal-title":"Circulation"},{"issue":"2","key":"1198_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1198_CR34","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc16-0588","volume":"39","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Williams B, Lisheng L, et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care. 2016;39(10):1796\u2013803.","journal-title":"Diabetes Care"},{"issue":"5","key":"1198_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/dc17-2062","volume":"41","author":"ST Andersen","year":"2018","unstructured":"Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 Years: ADDITION-Denmark. Diabetes Care. 2018;41(5):1068\u201375.","journal-title":"Diabetes Care"},{"key":"1198_CR36","first-page":"137289","volume":"2012","author":"G Barrera","year":"2012","unstructured":"Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:137289.","journal-title":"ISRN Oncol"},{"issue":"9","key":"1198_CR37","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.freeradbiomed.2012.02.035","volume":"52","author":"JK Kundu","year":"2012","unstructured":"Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic Biol Med. 2012;52(9):2013\u201337.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1198_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/db15-0564","volume":"65","author":"M Long","year":"2016","unstructured":"Long M, de la Rojo Vega M, Wen Q, Bharara M, Jiang T, Zhang R, et al. An essential role of NRF2 in diabetic wound healing. Diabetes. 2016;65(3):780\u201393.","journal-title":"Diabetes"},{"key":"1198_CR39","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0695","author":"M Nativel","year":"2018","unstructured":"Nativel M, Schneider F, Saulnier PJ, Gand E, Ragot S, Meilhac O, et al. Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes. Diabetes Care. 2018. https:\/\/doi.org\/10.2337\/dc18-0695.","journal-title":"Diabetes Care"},{"key":"1198_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12933-014-0163-2","volume":"14","author":"K Mohammedi","year":"2015","unstructured":"Mohammedi K, Bellili-Munoz N, Marklund SL, Driss F, Le Nagard H, Patente TA, et al. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes. Cardiovasc Diabetol. 2015;14:845.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1198_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/2047487319884246","volume":"27","author":"T Toya","year":"2020","unstructured":"Toya T, Sara JD, Corban MT, Taher R, Godo S, Herrmann J, et al. Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer. Eur J Prev Cardiol. 2020;27(6):608\u201318.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"1198_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1152\/physrev.00001.2017","volume":"98","author":"G Eelen","year":"2018","unstructured":"Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW, Carmeliet P. Endothelial Cell Metabolism. Physiol Rev. 2018;98(1):3\u201358.","journal-title":"Physiol Rev"},{"issue":"4","key":"1198_CR43","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586\u2013613.","journal-title":"Circulation"},{"issue":"12","key":"1198_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.112.001183","volume":"127","author":"LJ Rasmussen-Torvik","year":"2013","unstructured":"Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, et al. Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study. Circulation. 2013;127(12):1270\u20135.","journal-title":"Circulation"},{"issue":"Suppl 5","key":"1198_CR45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2009.0078","volume":"7","author":"MD Stubblefield","year":"2009","unstructured":"Stubblefield MD, Burstein HJ, Burton AW, Custodio CM, Deng GE, Ho M, et al. NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw. 2009;7(Suppl 5):S1\u201326.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-020-01198-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T21:07:26Z","timestamp":1609794446000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01198-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01198-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"26 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Ethics Committee of each participating centre approved the ADVANCE study, and all participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MW is a consultant to Amgen and Kyowa Kirin. Authors declare no other potential conflict of interest relevant to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}